superb Superblock of Sant Antoni reclaims Barcelona streets for pedestrians By inhabitat.com Published On :: Thu, 07 May 2020 15:30:00 +0000 As part of Barcelona’s efforts to reclaim its car-congested streets for pedestrians, the city has tapped architects to create "superblocks” — groups of streets transformed into car-free public plazas. One such project was completed in 2019 by Leku Studio in the trendy neighborhood of Sant Antoni. Redesigned with attractive way-finding elements and street furniture, the Superblock of Sant Antoni is the second of six superblocks completed to date.[...] Full Article Urban design urban planning public space air pollution Barcelona pedestrian friendly public plaza street furniture car free urban furniture superblock way finding Public Spaces Leku Studio Superblock of Sant Antoni cyclist friendly
superb Watching the Superb Owl with this magnificent fluffer Frank.... By ceejbot.tumblr.com Published On :: Sun, 02 Feb 2020 15:55:07 -0800 Watching the Superb Owl with this magnificent fluffer Frank. https://ift.tt/2Ok6r0O Full Article instagram photography life
superb Girls’ superb verbal skills may contribute to the gender gap in math By www.pbs.org Published On :: Girls are great at math. But if they’re even better at reading, they might be more motivated to choose a humanities-focused career. Full Article
superb Review: 'A White, White Day' delivers a superb psychological puzzle worth piecing together By www.latimes.com Published On :: Thu, 16 Apr 2020 20:03:44 -0400 Icelandic filmmaker Hlynur Pálmason's award-winning second feature, "A White, White Day," is a gripping, ruminative drama of grief and revenge. Full Article
superb Skoda Karoq, new Rapid and Superb digital launch likely on May 6 By www.financialexpress.com Published On :: 2020-04-23T16:44:57+05:30 The Skoda Superb, as well as the Rapid, will be facelifted models while the Karoq is an all-new offering that might be brought in limited numbers. Full Article
superb Skoda Superb facelift bookings start online: Expected price, launch, specs, features By www.financialexpress.com Published On :: 2020-04-30T11:13:10+05:30 The Skoda Superb facelift has a 2.0-litre petrol engine and Matrix LED headlights while its competitor will be the Toyota Camry hybrid. Full Article
superb Skoda Superb recalled in India for this fault: More than 2,000 cars affected By www.financialexpress.com Published On :: 2020-05-03T12:46:13+05:30 The affected Skoda Superb units were manufactured between 2013-15 and the repair work will hardly take 30 minutes. Full Article
superb Rise of the electric motorcycle: Top 10 all-electric scooters & superbikes of 2019 By www.financialexpress.com Published On :: 2019-05-06T13:16:00+05:30 Full Article
superb SuperBackup 2.0.5 Persistent Cross Site Scripting By packetstormsecurity.com Published On :: Wed, 15 Apr 2020 18:29:35 GMT SuperBackup version 2.0.5 for iOS suffers from a persistent cross site scripting vulnerability. Full Article
superb Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir [Pharmacology] By aac.asm.org Published On :: 2020-04-21T08:01:09-07:00 In children requiring lopinavir coformulated with ritonavir in a 4:1 ratio (lopinavir-ritonavir-4:1) and rifampin, adding ritonavir to achieve a 4:4 ratio with lopinavir (LPV/r-4:4) overcomes the drug-drug interaction. Possible drug-drug interactions within this regimen may affect abacavir concentrations, but this has never been studied. Children weighing <15 kg needing rifampin and LPV/r-4:4 were enrolled in a pharmacokinetic study and underwent intensive pharmacokinetic sampling on 3 visits: (i) during the intensive and (ii) continuation phases of antituberculosis treatment with LPV/r-4:4 and (iii) 1 month after antituberculosis treatment completion on LPV/r-4:1. Pharmacometric modeling and simulation were used to compare exposures across weight bands with adult target exposures. Eighty-seven children with a median (interquartile range) age and weight of 19 (4 to 64) months and 8.7 (3.9 to 14.9) kg, respectively, were included in the abacavir analysis. Abacavir pharmacokinetics were best described by a two-compartment model with first-order elimination and transit compartment absorption. After allometric scaling adjusted for the effect of body size, maturation could be identified: clearance was predicted to be fully mature at about 2 years of age and to reach half of this mature value at about 2 months of age. Abacavir bioavailability decreased 36% during treatment with rifampin and LPV/r-4:4 but remained within the median adult recommended exposure, except for children in the 3- to 4.9-kg weight band, in which the exposures were higher. The observed predose morning trough concentrations were higher than the evening values. Though abacavir exposure significantly decreased during concomitant administration of rifampin and LPV/r-4:4, it remained within acceptable ranges. (This study is registered in ClinicalTrials.gov under identifier NCT02348177.) Full Article
superb For All Mankind review: A superb alternative history of the space race By www.newscientist.com Published On :: Wed, 19 Feb 2020 18:00:00 +0000 When the Soviet Union lands on the moon first people in the US are shocked. But For All Mankind provides an even bigger surprise when one cosmonaut's identity is revealed, says Emily Wilson Full Article
superb Angela Merkel praised for 'superb' explanation on how coronavirus infection rates impact healthcare systems By www.standard.co.uk Published On :: 2020-04-16T13:27:00Z Follow our live coronavirus updates HERE Coronavirus: The symptoms Full Article
superb #DesignYourSuperBear: John Lewis and Waitrose launch soft toy design competition for UK kids By www.standard.co.uk Published On :: 2020-04-22T13:15:19Z 100% of the proceeds will go towards the NHS Full Article
superb 5 Superb Skin Care Products That Every Man Tired Of Acne Needs in His Life By www.mensxp.com Published On :: Fri, 08 May 2020 08:00:00 +0530 Full Article Skincare
superb Review: The moving drama 'Driveways' features a superb Brian Dennehy in one of his last roles By www.latimes.com Published On :: Wed, 6 May 2020 15:27:23 -0400 Andrew Ahn's lovely second feature "Driveways" also stars Hong Chau and Lucas Jaye. Full Article
superb Superb Button excels in the wet By en.espnf1.com Published On :: Sun, 18 Apr 2010 10:05:53 GMT Jenson Button secured a superb win in the wet at the Chinese Grand Prix, and with team-mate Lewis Hamilton taking second, it completed an excellent weekend for the McLarens Full Article
superb Advancing antibiotic development in the age of 'superbugs' By webfeeds.brookings.edu Published On :: Fri, 27 Feb 2015 14:37:00 -0500 While antibiotics are necessary and crucial for treating bacterial infections, their misuse over time has contributed to a rather alarming rate of antibiotic resistance, including the development of multidrug-resistance bacteria or “super bugs.” Misuse manifests throughout all corners of public and private life; from the doctor’s office when prescribed to treat viruses; to industrial agriculture, where they are used in abundance to prevent disease in livestock. New data from the World Health Organization (WHO) and U.S. Centers for Disease Control and Prevention (CDC) confirm that rising overuse of antibiotics has already become a major public health threat worldwide. As drug resistance increases, we will see a number of dangerous and far-reaching consequences. First, common infections like STDs, pneumonia, and “staph” infections will become increasingly difficult to treat, and in extreme cases these infections may require hospitalization or treatment with expensive and toxic second-line therapies. In fact, recent estimates suggest that every year more than 23,000 people die due to drug-resistant infections in the U.S., and many more suffer from complications caused by resistant pathogens. Further, infections will be harder to control. Health care providers are increasingly encountering highly resistant infections not only in hospitals – where such infections can easily spread between vulnerable patients – but also in outpatient care settings. Fundamental Approaches to Slowing Resistance Incentivize appropriate use of antibiotics. Many patients and providers underestimate the risks of using antibiotics when they are not warranted, in part because these drugs often have rapid beneficial effects for those who truly need them. In many parts of the world the perception that antibiotics carry few risks has been bolstered by their low costs and availability without a prescription or contact with a trained health care provider. Education efforts, stewardship programs, and the development of new clinical guidelines have shown some success in limiting antibiotic use, but these fixes are limited in scope and generally not perceived as cost-effective or sustainable. Broader efforts to incentivize appropriate use, coupled with economic incentives, may be more effective in changing the culture of antibiotic use. These options might include physician or hospital report cards that help impact patient provider selection, or bonuses based on standardized performance measures that can be used to report on success of promoting appropriate use. While these might create additional costs, they would likely help control rates of drug resistant infections and outweigh the costs of treating them. Reinvigorate the drug development pipeline with novel antibiotics. There has not been a new class of antibiotics discovered in almost three decades, and companies have largely left the infectious disease space for more stable and lucrative product lines, such as cancer and chronic disease. Antibiotics have historically been inexpensive and are typically used only for short periods of time, creating limited opportunities for return on investment. In addition, unlike cancer or heart disease treatments, antibiotics lose effectiveness over time, making them unattractive for investment. Once they are on the market, the push to limit use of certain antibiotics to the most severe infections can further constrict an already weak market. Late last year, H.R. 3742, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, was introduced and referred to the House Energy and Commerce Subcommittee on Health. If enacted, the ADAPT Act would create a streamlined development pathway to expedite the approval of antibiotics that treat limited patient populations with serious unmet medical needs. This could potentially reduce costs and development time for companies, thereby encouraging investment in this space. Regulators have indicated that they would also welcome the opportunity to evaluate benefits and risk for a more selective patient subpopulation if they could be confident the product would be used appropriately. The bill has received a great deal of support and would help address a critical public health need (I cover this topic in more detail with my colleagues Kevin Outterson, John Powers, and Mark McClellan in a recent Health Affairs paper). Advance new economic incentives to remedy market failure. Innovative changes to pharmaceutical regulation, research and development (R&D), and reimbursement are necessary to alleviate the market failure for antibacterial drugs. A major challenge, particularly within a fee-for-service or volume-based reimbursement system, is providing economic incentives that promote investment in drug development without encouraging overuse. A number of public and private stakeholders, including the Engelberg Center for Health Care Reform and Chatham House’s Centre on Global Health Security Working Group on Antimicrobial Resistance, are exploring alternative reimbursement mechanisms that “de-link” revenue from the volume of antibiotics sold. Such a mechanism, combined with further measures to stimulate innovation, could create a stable incentive structure to support R&D. Improve tracking and monitoring of resistance in the outpatient setting. There is increasing concern about much less rigorous surveillance capabilities in the outpatient setting, where drug-resistant infections are also on the rise. Policymakers should consider new incentives for providers and insurers to encourage a coordinated approach for tracking inpatient and outpatient resistance data. The ADAPT Act, mentioned above, also seeks to enhance monitoring of antibiotic utilization and resistance patterns. Health insurance companies can leverage resistance-related data linked to health care claims, while providers can capture lab results in electronic health records. Ultimately, this data could be linked to health and economic outcomes at the state, federal, and international levels, and provide a more comprehensive population-based understanding of the impact and spread of resistance. Current examples include the Food and Drug Administration’s (FDA) Sentinel Initiative and the Patient-Centered Outcomes Research Institute’s PCORnet initiative. Antibiotic resistance is an urgent and persistent threat. As such, patients and providers will continue to require new antibiotics as older drugs are forced into retirement by resistant pathogens. Stewardship efforts will remain critical in the absence of game-changing therapies that parry resistance mechanisms. Lastly, a coordinated surveillance approach that involves diverse stakeholder groups is needed to understand the health and economic consequences of drug resistance, and to inform antibiotic development and stewardship efforts. Editor's note: This blog was originally posted in May 2014 on Brookings UpFront. Authors Gregory W. Daniel Full Article
superb Advancing antibiotic development in the age of 'superbugs' By webfeeds.brookings.edu Published On :: Fri, 27 Feb 2015 14:37:00 -0500 While antibiotics are necessary and crucial for treating bacterial infections, their misuse over time has contributed to a rather alarming rate of antibiotic resistance, including the development of multidrug-resistance bacteria or “super bugs.” Misuse manifests throughout all corners of public and private life; from the doctor’s office when prescribed to treat viruses; to industrial agriculture, where they are used in abundance to prevent disease in livestock. New data from the World Health Organization (WHO) and U.S. Centers for Disease Control and Prevention (CDC) confirm that rising overuse of antibiotics has already become a major public health threat worldwide. As drug resistance increases, we will see a number of dangerous and far-reaching consequences. First, common infections like STDs, pneumonia, and “staph” infections will become increasingly difficult to treat, and in extreme cases these infections may require hospitalization or treatment with expensive and toxic second-line therapies. In fact, recent estimates suggest that every year more than 23,000 people die due to drug-resistant infections in the U.S., and many more suffer from complications caused by resistant pathogens. Further, infections will be harder to control. Health care providers are increasingly encountering highly resistant infections not only in hospitals – where such infections can easily spread between vulnerable patients – but also in outpatient care settings. Fundamental Approaches to Slowing Resistance Incentivize appropriate use of antibiotics. Many patients and providers underestimate the risks of using antibiotics when they are not warranted, in part because these drugs often have rapid beneficial effects for those who truly need them. In many parts of the world the perception that antibiotics carry few risks has been bolstered by their low costs and availability without a prescription or contact with a trained health care provider. Education efforts, stewardship programs, and the development of new clinical guidelines have shown some success in limiting antibiotic use, but these fixes are limited in scope and generally not perceived as cost-effective or sustainable. Broader efforts to incentivize appropriate use, coupled with economic incentives, may be more effective in changing the culture of antibiotic use. These options might include physician or hospital report cards that help impact patient provider selection, or bonuses based on standardized performance measures that can be used to report on success of promoting appropriate use. While these might create additional costs, they would likely help control rates of drug resistant infections and outweigh the costs of treating them. Reinvigorate the drug development pipeline with novel antibiotics. There has not been a new class of antibiotics discovered in almost three decades, and companies have largely left the infectious disease space for more stable and lucrative product lines, such as cancer and chronic disease. Antibiotics have historically been inexpensive and are typically used only for short periods of time, creating limited opportunities for return on investment. In addition, unlike cancer or heart disease treatments, antibiotics lose effectiveness over time, making them unattractive for investment. Once they are on the market, the push to limit use of certain antibiotics to the most severe infections can further constrict an already weak market. Late last year, H.R. 3742, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, was introduced and referred to the House Energy and Commerce Subcommittee on Health. If enacted, the ADAPT Act would create a streamlined development pathway to expedite the approval of antibiotics that treat limited patient populations with serious unmet medical needs. This could potentially reduce costs and development time for companies, thereby encouraging investment in this space. Regulators have indicated that they would also welcome the opportunity to evaluate benefits and risk for a more selective patient subpopulation if they could be confident the product would be used appropriately. The bill has received a great deal of support and would help address a critical public health need (I cover this topic in more detail with my colleagues Kevin Outterson, John Powers, and Mark McClellan in a recent Health Affairs paper). Advance new economic incentives to remedy market failure. Innovative changes to pharmaceutical regulation, research and development (R&D), and reimbursement are necessary to alleviate the market failure for antibacterial drugs. A major challenge, particularly within a fee-for-service or volume-based reimbursement system, is providing economic incentives that promote investment in drug development without encouraging overuse. A number of public and private stakeholders, including the Engelberg Center for Health Care Reform and Chatham House’s Centre on Global Health Security Working Group on Antimicrobial Resistance, are exploring alternative reimbursement mechanisms that “de-link” revenue from the volume of antibiotics sold. Such a mechanism, combined with further measures to stimulate innovation, could create a stable incentive structure to support R&D. Improve tracking and monitoring of resistance in the outpatient setting. There is increasing concern about much less rigorous surveillance capabilities in the outpatient setting, where drug-resistant infections are also on the rise. Policymakers should consider new incentives for providers and insurers to encourage a coordinated approach for tracking inpatient and outpatient resistance data. The ADAPT Act, mentioned above, also seeks to enhance monitoring of antibiotic utilization and resistance patterns. Health insurance companies can leverage resistance-related data linked to health care claims, while providers can capture lab results in electronic health records. Ultimately, this data could be linked to health and economic outcomes at the state, federal, and international levels, and provide a more comprehensive population-based understanding of the impact and spread of resistance. Current examples include the Food and Drug Administration’s (FDA) Sentinel Initiative and the Patient-Centered Outcomes Research Institute’s PCORnet initiative. Antibiotic resistance is an urgent and persistent threat. As such, patients and providers will continue to require new antibiotics as older drugs are forced into retirement by resistant pathogens. Stewardship efforts will remain critical in the absence of game-changing therapies that parry resistance mechanisms. Lastly, a coordinated surveillance approach that involves diverse stakeholder groups is needed to understand the health and economic consequences of drug resistance, and to inform antibiotic development and stewardship efforts. Editor's note: This blog was originally posted in May 2014 on Brookings UpFront. Authors Gregory W. Daniel Full Article
superb Weekend Movies in Review: Superbad and The 11th Hour By www.treehugger.com Published On :: Tue, 21 Aug 2007 15:28:11 -0400 So if you’re anything like me, you’ve been waiting as patiently as you could for Aug 17. Last Friday was the opening weekend for two highly anticipated films: Superbad starring Jonah Hill, Michael Cera & Seth Rogen, and The 11th Hour directed by Full Article Living
superb 10th-century Anglo Saxon potion kills MRSA superbug By www.treehugger.com Published On :: Wed, 10 Apr 2019 16:40:10 -0400 A microbiologist and an Anglo Saxon scholar decided to test a recipe from an Old English medical compendium called Bald's Leechbook, what they found surprised everyone. Full Article Living
superb Superbook turns your Android smart phone into a complete laptop By www.treehugger.com Published On :: Thu, 21 Jul 2016 12:17:59 -0400 It may well be all most people need as a computer, and it may well be what we have been waiting for. Full Article Design
superb Mumbai: 'Malfunctioning' superbike causes Virar man's death By www.mid-day.com Published On :: 03 Dec 2018 15:00:06 GMT A nagging defect in his superbike allegedly led to the death of biker Zoheb Merchant, 28, on Sunday morning. The Virar resident was on his way home after a joyride with his biker gang, when the front brake of his MV Agusta F3 800 jammed at Manor, throwing him off in another direction. This was the third time his superbike had malfunctioned since he bought it. Merchant is survived by his parents, three brothers, wife and a six-year-old son. He was the eldest in the family and had a business selling firecrackers. The incident occurred on Sunday morning when Merchant and his group of 15-18 bikers had gone on their usual Sunday ride from Virar to Dahanu. When they were on their way back, the front brake of Merchant's bike allegedly jammed, leading him to lose control of the bike and ram into a divider. Front brake of Merchant's bike allegedly jammed, leading him to lose control of bike and ram into divider. One of his friends said, "We have a bikers' group and every Sunday morning, we ride the bike while following proper safety and traffic norms. Whatever happened came as a huge shock to us. Suddenly, some defect occurred in his bike, jamming the brake of the front tyre disc, which then led to him losing control of the bike and falling on the road." Third time Since they were riding at full speed, the impact of the malfunction became such that he was thrown off the bike in another direction. His vehicle, meanwhile, fell near the direction of the Ahmedabad-Mumbai National Highway. Merchant's bike is manufactured by the Italian motorcycle maker MV Agusta, and retails for around R 20 lakh. According to his friends, since he bought it, he'd faced the same defect twice, which is an electric malfunction that jams the front tyre disc. He'd got it fixed and extended the vehicle's warranty till March 2019. He'd also written a Facebook post about the earlier issues he faced. However, the same defect occurred a third time, leading to his death. Cause of death not known Another friend said, " We managed to bring an ambulance to the spot and took him to a government hospital on the highway, where he was declared dead on arrival. Looking at his body, doctors were shocked at not finding any external injuries." He had minor injuries on his head due to the impact of the fall. The cause of death has not been revealed as the post-mortem report is yet to be released. His friends suspect he died of internal bleeding. This is the third time the MV Agusta 800 had allegedly malfunctioned. While the case had initially been registered at the Virar police station, the matter has been transferred to the Manor police station as the incident occurred in their jurisdiction. An officer from Virar police station said, "We have registered a case under section 304( a) ( death by negligence) of the Indian Penal Code and various sections of the Motor Vehicles Act against unidentified accused." Motoroyale, the dealer from whom Merchant bought the bike, couldn't be reached for comment. 18 No. of bikers in Zoheb's group 3 No. of times his bike glitched Catch up on all the latest Mumbai news, crime news, current affairs, and also a complete guide on Mumbai from food to things to do and events across the city here. Also download the new mid-day Android and iOS apps to get latest updates Full Article
superb Watch Out: 'Superbugs' Often Found on Many Hospital Patients' Hands By www.medindia.net Published On :: Hospital patient's hands contain dangerous 'superbugs' that can trigger a wide range of hospital-related infections, reports a new study. For decades, Full Article
superb Stemming the Superbug Tide in Poland By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistance proportions for eight antibiotic-bacterium pairs in Poland have increased in recent years, from 22% in 2005 to 25% in 2015, and could go up to 26% by 2030, should current trends in antibiotic consumption, population and economic growth continue into the future. Resistance proportions in Poland were higher than the OECD average in 2015 (17%). Full Article
superb Stemming the Superbug Tide in the United States By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistance proportions for eight antibiotic-bacterium pairs in the United States have increased in recent years, from 20% in 2005 to 23% in 2015, and could go up to 25% by 2030, should current trends in antibiotic consumption, population and economic growth continue into the future. Resistance proportions in the United States were higher than the OECD average in 2015 (17%). Full Article
superb Stemming the Superbug Tide in Canada By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistance proportions for eight antibiotic-bacterium pairs in Canada have been stable around 14% between 2005 and 2015, and are not predicted to increase by 2030, should current trends in antibiotic consumption, population and economic growth continue into the future. Resistance proportions in Canada were lower than the OECD average in 2015 (17%). Full Article
superb Stemming the Superbug Tide in the Netherlands By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistance proportions for eight antibiotic-bacterium pairs in the Netherlands have slightly increased in recent years, from 3% in 2005 to 5% in 2015, and could go up to 6% by 2030, should current trends in antibiotic consumption, population and economic growth continue into the future. Resistance proportions in the Netherlands were markedly lower than the OECD average in 2015. Full Article
superb Het “Superbug” Tij Keren In Nederland By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistentie onder acht antibiotica-bacterie paren is licht gestegen in de laatste jaren, van 3% in 2005 naar 5% in 2015. Dit kan toenemen tot 6% in 2030 als de huidige trends in antibioticaconsumptie, bevolkingsomvang en economische groei doorzetten. De resistentie prevalentie in Nederland is aanmerkelijk lager dan het OESO gemiddelde in 2015 (17%). Full Article
superb Stemming the Superbug Tide in Australia By www.oecd.org Published On :: Wed, 07 Nov 2018 11:00:00 GMT Resistance proportions for eight antibiotic-bacterium pairs in Australia have increased in recent years, from 7% in 2005 to 10% in 2015, and could go up to 12% by 2030, should current trends in antibiotic consumption, population and economic growth continue into the future. Resistance proportions in Australia were lower than the OECD average in 2015 (17%). Full Article
superb Coronavirus lessons for the fight against ‘superbugs’ By www.ft.com Published On :: Tue, 05 May 2020 03:31:40 GMT The world needs to act now to avert the threat from antimicrobial resistance Full Article
superb Superbacklash By feedproxy.google.com Published On :: Wed, 03 Jul 2019 06:29:16 +0000 Hot startup Superhuman has been getting some backlash, as often happens when someone notices the precise methodology that a startup is using to enable a core feature. We’re well into stage 2 now when, inevitably, the backlash itself gets backlash. The nut of it is that people have been exposed to the idea that Superhuman […] Full Article Startups TC Apple cyberspace designer email Groupon Marketing mike davidson spamming Startup company superhuman
superb Kanye West looks glum just days before his Superbowl Sunday Service in Miami By www.dailymail.co.uk Published On :: Sat, 01 Feb 2020 04:32:21 GMT Kanye West seemed somber when he was spotted leaving his office in Calabasas. The 42-year-old rapper opted for a street casual look on Friday. Full Article
superb Strictly superb from Louis Smith as he roars back with superb performance in Glasgow By www.dailymail.co.uk Published On :: Tue, 29 Jul 2014 08:14:36 GMT The last time Louis Smith competed in front of a crowd this size he was doing a shirtless showdance in the final of Strictly Come Dancing. There was more material, fewer sequins, but the same strength and poise involved as he returned to the day job of trying to win gold medals. Full Article
superb Padraig Harrington shoots superb 63 in opening round of Irish Open By www.dailymail.co.uk Published On :: Thu, 04 Jul 2019 22:02:29 GMT One day after ridiculing the idea that odds of 100-1 represented any sort of value on him winning the Irish Open, Padraig Harrington opened with a marvellous 63 for a one-stroke lead. Full Article
superb Jennifer Lopez wears leggings from Tammy Hembrow's brand during Superbowl halftime rehearsals By www.dailymail.co.uk Published On :: Wed, 05 Feb 2020 08:18:11 GMT Tammy Hembrow beamed with pride when she featured in a billboard ad in Times Square, New York. Full Article
superb Instagram model, 27,who streaked at Superbowl says security gave her bruises and ripped her dress By www.dailymail.co.uk Published On :: Fri, 07 Feb 2020 07:32:13 GMT Instagram model Kelly Kay Green, 27, was revealed as the Superbowl Streaker who was bruised and had her dress ripped as six security guards tackled her to the ground to arrest her. Full Article
superb Juventus 4-0 Udinese: Gonzalo Higuain finishes superb move after THREE one-twos with Paolo Dybala By www.dailymail.co.uk Published On :: Wed, 15 Jan 2020 23:45:53 GMT JUVENTUS 4-0 UDINESE: Juventus, missing Cristiano Ronaldo with sinusitis, went ahead with a delightful goal after 16 minutes that had all the hallmarks of their coach Maurizio Sarri. Full Article
superb Madonna review: The spectacle has been superb, the music patchy, the time-keeping abysmal By Published On :: Sat, 04 Jan 2020 22:01:39 +0000 'Madonna?' said the immigration officer at JFK. 'She's, like, 70, right?' Well, no - she's 61, and determined to prove that 61 is the new 31. Full Article
superb Brentford 0-1 Birmingham: Kristian Pedersen's superb header secures victory for visitors By Published On :: Sat, 03 Aug 2019 17:44:26 +0100 TOM FARMERY AT GRIFFIN PARK: Brentford manager Thomas Frank will wonder how his side didn't score at least three times in their opening day defeat to Birmingham. Full Article
superb Madonna review: The spectacle has been superb, the music patchy, the time-keeping abysmal By www.dailymail.co.uk Published On :: Sat, 04 Jan 2020 22:01:39 GMT 'Madonna?' said the immigration officer at JFK. 'She's, like, 70, right?' Well, no - she's 61, and determined to prove that 61 is the new 31. Full Article
superb Harry Styles apologises to fans as he cancels pre-Superbowl event because of a severe storm in Miami By www.dailymail.co.uk Published On :: Tue, 04 Feb 2020 09:23:24 GMT The singer, 26, took to Twitter on Saturday to break the news to his followers, and apologise to them as he admitted he was 'so disappointed' by what had happened. Full Article
superb Sharm El-Sheikh offers superb diving - and with direct flights from next week it is back in business By www.dailymail.co.uk Published On :: Mon, 16 Dec 2019 09:01:33 GMT After four years of negotiations and a huge investment in security, Sharm El-Sheikh airport is preparing for direct flights from the UK. Mark Jones went and found some amazing bargains. Full Article
superb A great week for speed fans: Ferrari deliver 'superb levels of performance' and Jose Mourinho picks up the first Jaguar F-type coupe By www.dailymail.co.uk Published On :: Sun, 16 Feb 2014 18:46:57 GMT The 200 mph California T is set to roar into Britain from September after its world debut at next month's Geneva Motor Show, whilst the Jaguar F-Type sports coupe was launched this week. Full Article
superb Marcus Rashford wins Premier League Player of the Month award for superb performances in January By Published On :: Fri, 08 Feb 2019 16:57:55 +0000 Marcus Rashford has won the Premier League Player of the Month award for his superb performances in January. The Manchester United striker has been rejuvenated under boss Ole Gunnar Solskjaer. Full Article
superb Superbloom is out of this world! NASA image shows a sea of orange poppies in southern California By www.dailymail.co.uk Published On :: Wed, 06 May 2020 19:24:41 GMT A 'March Miracle' brought significant rainfall to southern California that birthed fields of orange poppies and NASA shared an image showing a sea of wildflowers as seen from space. Full Article
superb Skoda India teases the New Superb in Legacy Of SKODA Video! By www.business-standard.com Published On :: Fri, 29 Jan 2016 15:42:53 +0530 Vehicles have long been a true reflection of the progress of man. The innovations in the field of auto have been paralleled by very few. 29th of January is regarded as World Automotive Day. A tribute to all things on wheels, the day reflects upon ... Full Article
superb 2016 Skoda Superb Teased Ahead of Indian Auto Expo By www.business-standard.com Published On :: Tue, 02 Feb 2016 13:46:16 +0530 Skoda’s flagship car, the Superb, has been teased in its 2016 avatar on the manufacturer’s official website. The manufacturer is not participating in the latest iteration of Indian Auto Expo. The luxury sedan is expected to be launched in the ... Full Article
superb The Superbugs are here By indiatogether.org Published On :: Tue, 31 May 2011 00:00:00 +0000 For decades, antibiotics have been used carelessly in India, with doctors, pharmacists, patients and drug companies all contributing to their abuse. The results could be catastrophic. Ramesh Menon reports. Click here to read Part II Full Article
superb The Superbugs are here - II By indiatogether.org Published On :: Tue, 14 Jun 2011 00:00:00 +0000 Superbugs will alter the course of medical history. India needs to put in place proper systems that will ensure that drug resistance does not set in. Ramesh Menon reports. Click here to read Part I Full Article
superb The Superbugs are here - III By indiatogether.org Published On :: Tue, 08 Nov 2011 00:00:00 +0000 The Government's response to the emergence of Superbugs should be urgent and specific, but instead it has been living in denial even as the threat multiplies, writes Ramesh Menon. Click here to read Part I | Part II Full Article
